Works matching IS 10837159 AND DT 2019 AND VI 24 AND IP 2
Results: 24
Tobacco Use Assessment and Treatment in Cancer Patients: A Scoping Review of Oncology Care Clinician Adherence to Clinical Practice Guidelines in the U.S.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 229, doi. 10.1634/theoncologist.2018-0246
- By:
- Publication type:
- Article
A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 161, doi. 10.1634/theoncologist.2018-0654
- By:
- Publication type:
- Article
Phase II Trial of 5‐Fluorouracil, Docetaxel, and Nedaplatin (UDON) Combination Therapy for Recurrent or Metastatic Esophageal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 163, doi. 10.1634/theoncologist.2018-0653
- By:
- Publication type:
- Article
Enrichment of HER2 Amplification in Brain Metastases from Primary Gastrointestinal Malignancies.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 193, doi. 10.1634/theoncologist.2018-0152
- By:
- Publication type:
- Article
A Case of Metastatic Biliary Tract Cancer Diagnosed Through Identification of an IDH1 Mutation.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 151, doi. 10.1634/theoncologist.2018-0210
- By:
- Publication type:
- Article
Pilot Randomized Trial of a Pharmacy Intervention for Older Adults with Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 211, doi. 10.1634/theoncologist.2018-0408
- By:
- Publication type:
- Article
Takotsubo Cardiomyopathy During Anti‐HER2 Therapy for Metastatic Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. e80, doi. 10.1634/theoncologist.2018-0285
- By:
- Publication type:
- Article
Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1‐Deficient Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 146, doi. 10.1634/theoncologist.2018-0279
- By:
- Publication type:
- Article
A Prospective Trial Evaluating the Safety of a Shortened Infusion of Ramucirumab in Patients with Gastrointestinal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 159, doi. 10.1634/theoncologist.2018-0580
- By:
- Publication type:
- Article
A Longitudinal Study of the Association of Clinical Indices of Cardiovascular Autonomic Function with Breast Cancer Treatment and Exercise Training.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 273, doi. 10.1634/theoncologist.2018-0049
- By:
- Publication type:
- Article
Indirect Evaluation of Bone Saturation with Zoledronic Acid After Long‐Term Dosing.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 178, doi. 10.1634/theoncologist.2018-0218
- By:
- Publication type:
- Article
Cosmetic Consequences of Breast‐Conserving Treatment for Breast Cancer: Something Worth Talking About.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 172, doi. 10.1634/theoncologist.2017-0443
- By:
- Publication type:
- Article
Targeting Endoglin to Treat Metastatic Renal Cell Carcinoma: Lessons from Osler‐Weber‐Rendu Syndrome.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 143, doi. 10.1634/theoncologist.2018-0443
- By:
- Publication type:
- Article
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 185, doi. 10.1634/theoncologist.2018-0072
- By:
- Publication type:
- Article
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti‐Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 202, doi. 10.1634/theoncologist.2018-0299
- By:
- Publication type:
- Article
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 255, doi. 10.1634/theoncologist.2018-0191
- By:
- Publication type:
- Article
Patient‐Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 247, doi. 10.1634/theoncologist.2018-0317
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 219, doi. 10.1634/theoncologist.2018-0058
- By:
- Publication type:
- Article
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor‐Positive, HER‐2 Negative Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 165, doi. 10.1634/theoncologist.2018-0176
- By:
- Publication type:
- Article
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation‐Positive Non‐Small Cell Lung Cancer: A Prospective, Single‐Arm, Phase II Study.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 157, doi. 10.1634/theoncologist.2018-0120
- By:
- Publication type:
- Article
Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer?
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. e77, doi. 10.1634/theoncologist.2018-0180
- By:
- Publication type:
- Article
Anticancer Agent‐Induced Life‐Threatening Skin Toxicities: A Database Study of Spontaneous Reporting Data.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 266, doi. 10.1634/theoncologist.2017-0511
- By:
- Publication type:
- Article
Training for Medical Oncologists on Shared Decision‐Making About Palliative Chemotherapy: A Randomized Controlled Trial.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 259, doi. 10.1634/theoncologist.2018-0090
- By:
- Publication type:
- Article
Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 239, doi. 10.1634/theoncologist.2017-0668
- By:
- Publication type:
- Article